ProtoMed Inc.
This article was originally published in Start Up
Executive Summary
ProtoMed was founded to develop a class of serine-protease inhibitors called Bowman Birk Inhibitors, from soy. The drugs have potential activity against a wide variety of infllammatory gastroenterological disorders and cancers.